UB Paderborn / Katalog / Suche / in CDI

1 – 17 von 17

Sortiert nach

Sildenafil restores cognitive function without affecting β‐amyloid burden in a mouse model of Alzheimer's disease

British journal of pharmacology, 2011-12, Vol.164 (8), p.2029-2041

2011

Volltextzugriff (PDF)

Defining the mechanism of action of 4-phenylbutyrate to develop a small-molecule-based therapy for Alzheimer's disease

Current medicinal chemistry, 2011-12, Vol.18 (36), p.5545

2011

Volltextzugriff (PDF)

Decreased levels of guanosine 3′, 5′-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

Neuropathology and applied neurobiology, 2015-06, Vol.41 (4), p.471-482

2015

Volltextzugriff (PDF)

Abnormal α-Synuclein Interactions with Rab Proteins in α-Synuclein A30P Transgenic Mice

Journal of neuropathology and experimental neurology, 2004-04, Vol.63 (4), p.302-313

2004

Volltextzugriff (PDF)

Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer's disease

Clinical epigenetics, 2015-10, Vol.7 (1), p.108-108, Article 108

2015

Volltextzugriff (PDF)

La proteína priónica celular en el sistema nervioso central de mamíferos. Correlatos anatomoclínicos

Neurología (Barcelona, Spain), 2010-05, Vol.25 (4), p.228-233

2010

Volltextzugriff (PDF)

The cellular prion protein and its role in Alzheimer disease

Prion, 2009-04, Vol.3 (2), p.110-117

2009

Volltextzugriff (PDF)

Cellular prion protein in the central nervous system of mammals. Anatomoclinical associations

Neurología (Barcelona, Spain), 2010-05, Vol.25 (4), p.228-233

2010

Volltextzugriff (PDF)

Cellular prion protein in the central nervous system of mammals. Anatomoclinical associations

Neurología (Barcelona, English ed. ), 2010, Vol.25 (4), p.228-233

2010

Volltextzugriff (PDF)

Changes in cytoskeletal gene expression linked to MPTP-treatment in Mice

Neurobiology of disease, 2005-12, Vol.20 (3), p.666-672

2005

Volltextzugriff (PDF)

Sildenafil restores cognitive function without affecting [beta]-amyloid burden in a mouse model of Alzheimer's disease

British journal of pharmacology, 2011-12, Vol.164 (8), p.2029

2011

Volltextzugriff (PDF)

Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease: Reinstatement of cognitive function by sildenafil

British journal of pharmacology, 2011-12, Vol.164 (8), p.2029-2041

2011

Volltextzugriff (PDF)

Sildenafil restores cognitive function without affecting Delta b-amyloid burden in a mouse model of Alzheimer's disease

British journal of pharmacology, 2011-12, Vol.164 (8), p.2029-2041

2011

Volltextzugriff (PDF)

Insulin‐like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice

EMBO molecular medicine, 2014-10, Vol.6 (10), p.1246-1262

2014

Volltextzugriff (PDF)

Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy

Molecular therapy. Nucleic acids, 2019-06, Vol.16, p.26-37

2019

Volltextzugriff (PDF)

The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma

Neuro-oncology (Charlottesville, Va.), 2018-06, Vol.20 (7), p.930-941

2018

Volltextzugriff (PDF)

Decreased levels of guanosine 3′, 5′‐monophosphate (c GMP ) in cerebrospinal fluid ( CSF ) are associated with cognitive decline and amyloid pathology in A lzheimer's disease

Neuropathology and applied neurobiology, 2015-06, Vol.41 (4), p.471-482

2015

Volltextzugriff (PDF)

1 – 17 von 17

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(17)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Sildenafil restores cognitive function without affecting β‐amyloid burden in a mouse model of Alzheimer's disease

Defining the mechanism of action of 4-phenylbutyrate to develop a small-molecule-based therapy for Alzheimer's disease

Decreased levels of guanosine 3′, 5′-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease

Abnormal α-Synuclein Interactions with Rab Proteins in α-Synuclein A30P Transgenic Mice

Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer's disease

La proteína priónica celular en el sistema nervioso central de mamíferos. Correlatos anatomoclínicos

The cellular prion protein and its role in Alzheimer disease

Cellular prion protein in the central nervous system of mammals. Anatomoclinical associations

Cellular prion protein in the central nervous system of mammals. Anatomoclinical associations

Changes in cytoskeletal gene expression linked to MPTP-treatment in Mice

Sildenafil restores cognitive function without affecting [beta]-amyloid burden in a mouse model of Alzheimer's disease

Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease: Reinstatement of cognitive function by sildenafil

Sildenafil restores cognitive function without affecting Delta b-amyloid burden in a mouse model of Alzheimer's disease

Insulin‐like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice

Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy

The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma

Decreased levels of guanosine 3′, 5′‐monophosphate (c GMP ) in cerebrospinal fluid ( CSF ) are associated with cognitive decline and amyloid pathology in A lzheimer's disease

Suchergebnisse filtern